Meher, Bikash Ranjan <br/><br/>
Vaccine pharmacovigilance in India: Current context and future perspective 

 - Vol.51(4), July-Aug 
 - Mumbai  Wolter Kluwer  2019 
 - 243-247p. 
<br/><br/> Pharmacovigilance  of  vaccines  is  of  paramount  importance  to  promote  the  safe  use  of  vaccines  among their recipients. India launched the Adverse Events Following Immunization (AEFI) surveillance program in 1986 for monitoring suspected adverse events following immunization and since then, the AEFI surveillance guideline has been updated periodically, with the latest being in 2015. The successful AEFI surveillance program in India required the concerted effort of all stakeholders such as National AEFI Secretariat, National Technical Collaborating Centre, Central Drug Standard Control Organization, marketing authorization holder, and health‑care professionals 
<br/><br/><label>Subjects--Topical Terms: </label><br/>PHARMACOLOGY